arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

INSULET CORP

PODD
$141.10 ▲ +1.85 (+1.33%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
77
Health
Good
Bullish
auto_awesome

Analytical Summary

INSULET CORP shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $9.9B
Dividend Yield
Revenue Growth 33.9%
Op. Margin 16.0%
ROIC 7.6%
FCF / Share $1.28
Trailing P/E 108.5x
Price / Book 7.6x
FCF Yield 0.9%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$761.70M
↑ +33.9%
Net Income Profit after all expenses
$91.10M
↑ +157.3%
Operating Margin Operating profit as % of sales
16.0%
↓ -14.1% 71th
FCF / Share Free cash flow per share
$1.28
↑ +74.5%
Long-Term Debt Long-term obligations
$1.40B
— +0.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
68
Returns
82
Financial Health
82
Cash Quality
80

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters